CAR-NK Cells for Gastrointestinal Cancer Immunotherapy: From Bench to Bedside

The authors discuss the development and applications of chimeric antigen receptor (CAR)-natural killer (NK) cells in the treatment of gastrointestinal cancers (GI). They explore various sources of NK cells, CAR design strategies, and the current state of CAR-NK cell therapy for GI cancers.